Ameritas Investment Partners, Inc.
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 1055980
LINCOLN, NE
Position in ENTA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$24,918
-$6,196 QoQ
Shares Held
1,973
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ameritas Investment Partners, Inc. holds $51,229,440 across 216 Biotechnology names. ENTA ranks #166 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,563 | $5,609,881 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,656 | $3,597,411 | |
| 3 | EXEL |
Exelixis, Inc.
|
70,554 | $3,026,060 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
36,974 | $2,318,269 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
83,064 | $2,300,872 | |
| 6 | CYTK |
Cytokinetics Inc
|
32,284 | $2,127,838 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,194 | $2,116,225 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
35,392 | $1,999,294 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,918 | 1,973 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $31,114 | 1,973 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $23,616 | 1,973 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $14,915 | 1,973 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $10,890 | 1,973 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $11,344 | 1,973 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $20,440 | 1,973 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $25,589 | 1,973 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $34,448 | 1,973 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $18,565 | 1,973 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $22,038 | 1,973 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $31,607 | 1,477 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $59,729 | 1,477 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $68,710 | 1,477 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $76,611 | 1,477 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $69,817 | 1,477 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $105,132 | 1,477 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $110,450 | 1,477 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $83,908 | 1,477 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $72,968 | 1,658 | Shares | Other | 2021-08-06 | |
| 2021-03-31 | $81,772 | 1,658 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $69,801 | 1,658 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $75,903 | 1,658 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $83,248 | 1,658 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $77,556 | 1,508 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||